CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes Chief Financial Officer gave up 9,451 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 24,045 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 9,534 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 42,724 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,162 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 8,876 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,876 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,876 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,876 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,876 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,876 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,438 shares (option exercise)
- 4 Shares withheld for taxes Chief Legal Officer gave up 4,779 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 5,512 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,675 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,308 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,318 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President and CEO gave up 743 shares (to pay taxes)
Page 12 of 21 · 414 filings